Literature DB >> 29427072

Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Praveen Thokala1, Jessica Ochalek2, Ashley A Leech3, Thaison Tong4.   

Abstract

Cost-effectiveness (CE) thresholds are being discussed more frequently and there have been many new developments in this area; however, there is a lack of understanding about what thresholds mean and their implications. This paper provides an overview of the CE threshold literature. First, the meaning of a CE threshold and the key assumptions involved (perfect divisibility, marginal increments in budget, etc.) are highlighted using a hypothetical example, and the use of historic/heuristic estimates of the threshold is noted along with their limitations. Recent endeavours to estimate the empirical value of the thresholds, both from the supply side and the demand side, are then presented. The impact on CE thresholds of future directions for the field, such as thresholds across sectors and the incorporation of multiple criteria beyond quality-adjusted life-years as a measure of 'value', are highlighted. Finally, a number of common issues and misconceptions associated with CE thresholds are addressed.

Mesh:

Year:  2018        PMID: 29427072     DOI: 10.1007/s40273-017-0606-1

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  54 in total

1.  Systematic overview of cost-effectiveness thresholds in ten countries across four continents.

Authors:  Ruth Schwarzer; Ursula Rochau; Kim Saverno; Beate Jahn; Bernhard Bornschein; Nikolai Muehlberger; Magdalena Flatscher-Thoeni; Petra Schnell-Inderst; Gaby Sroczynski; Martina Lackner; Imke Schall; Ansgar Hebborn; Karl Pugner; Andras Fehervary; Diana Brixner; Uwe Siebert
Journal:  J Comp Eff Res       Date:  2015-09       Impact factor: 1.744

Review 2.  Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions.

Authors:  Irina Cleemput; Mattias Neyt; Nancy Thiry; Chris De Laet; Mark Leys
Journal:  Int J Technol Assess Health Care       Date:  2011-01-25       Impact factor: 2.188

3.  Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective.

Authors:  Michelle Remme; Melisa Martinez-Alvarez; Anna Vassall
Journal:  Value Health       Date:  2017-01-03       Impact factor: 5.725

Review 4.  Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.

Authors:  Samuel D Shillcutt; Damian G Walker; Catherine A Goodman; Anne J Mills
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Determinants of Change in the Cost-effectiveness Threshold.

Authors:  Mike Paulden; James O'Mahony; Christopher McCabe
Journal:  Med Decis Making       Date:  2016-09-27       Impact factor: 2.583

6.  International cross-section analysis of the determination of mortality.

Authors:  H S Gravelle; M E Backhouse
Journal:  Soc Sci Med       Date:  1987       Impact factor: 4.634

7.  Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force.

Authors:  William Crown; Nasuh Buyukkaramikli; Praveen Thokala; Alec Morton; Mustafa Y Sir; Deborah A Marshall; Jon Tosh; William V Padula; Maarten J Ijzerman; Peter K Wong; Kalyan S Pasupathy
Journal:  Value Health       Date:  2017-03       Impact factor: 5.725

8.  Insomnia treatment in New Zealand.

Authors:  Karyn M O'Keeffe; Philippa H Gander; W Guy Scott; Helen M Scott
Journal:  N Z Med J       Date:  2012-02-10

9.  Efficiency, equity, and budgetary policies: informing decisions using mathematical programming.

Authors:  David M Epstein; Zaid Chalabi; Karl Claxton; Mark Sculpher
Journal:  Med Decis Making       Date:  2007 Mar-Apr       Impact factor: 2.583

10.  Generalized cost-effectiveness analysis for national-level priority-setting in the health sector.

Authors:  Raymond Hutubessy; Dan Chisholm; Tessa Tan-Torres Edejer
Journal:  Cost Eff Resour Alloc       Date:  2003-12-19
View more
  35 in total

1.  Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee Osteoarthritis.

Authors:  Jean-Hugues Salmon; Anne-Christine Rat; Isabelle Charlot-Lambrecht; Jean-Paul Eschard; Damien Jolly; Bruno Fautrel
Journal:  Pharmacoeconomics       Date:  2018-11       Impact factor: 4.981

2.  Multi-criteria Decision Analysis Software in Healthcare Priority Setting: A Systematic Review.

Authors:  Alexander Moreno-Calderón; Thai S Tong; Praveen Thokala
Journal:  Pharmacoeconomics       Date:  2020-03       Impact factor: 4.981

3.  Cost-Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece.

Authors:  Gourzoulidis George; Koulentaki Maria; Kattamis Antonis; Bouzani Maria; Giatra Chara; Chotzagiannoglou Vassiliki; Beletsi Alexandra; Kourlaba Georgia
Journal:  Clin Drug Investig       Date:  2022-10-13       Impact factor: 3.580

Review 4.  Trimming the fat: is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review.

Authors:  Alexandra Gallagher; Blaise Agresta; Brendan Smyth; Meg Jardine; Charles Ferro; Rachael L Morton
Journal:  Clin Kidney J       Date:  2021-12-24

5.  Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine.

Authors:  Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; László Szilberhorn; Tamás Zelei; Balázs Nagy; Rositsa Koleva-Kolarova; Apostolos Tsiachristas; Sarah Wordsworth; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2021-04-16       Impact factor: 4.981

6.  Brief interventions to address substance use among patients presenting to emergency departments in resource poor settings: a cost-effectiveness analysis.

Authors:  Rebecca Dwommoh; Katherine Sorsdahl; Bronwyn Myers; Kwaku Poku Asante; Tracey Naledi; Dan J Stein; Susan Cleary
Journal:  Cost Eff Resour Alloc       Date:  2018-06-18

7.  Cost-effectiveness of a combined intervention of long lasting insecticidal nets and indoor residual spraying compared with each intervention alone for malaria prevention in Ethiopia.

Authors:  Alemayehu Hailu; Bernt Lindtjørn; Wakgari Deressa; Taye Gari; Eskindir Loha; Bjarne Robberstad
Journal:  Cost Eff Resour Alloc       Date:  2018-11-22

8.  Mutually Exclusive Interventions in the Cost-Effectiveness Bookshelf.

Authors:  Jonathan Siverskog; Martin Henriksson
Journal:  Med Decis Making       Date:  2020-03-14       Impact factor: 2.583

9.  Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data.

Authors:  Jessica Ochalek; James Lomas; Karl Claxton
Journal:  BMJ Glob Health       Date:  2018-11-05

10.  Cost-Effectiveness Model Shows Superiority of Wireless Spinal Cord Stimulation Implantation Without a Separate Trial.

Authors:  Richard B North; Harish S Parihar; Shawn D Spencer; Arthur F Spalding; Jane Shipley
Journal:  Neuromodulation       Date:  2020-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.